基本數據
| LEI | 988400ZJV6ISYBLQX875 |
| CIK | 1316426 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to KT&G Corporation
SEC Filings (Chronological Order)
本頁面提供了一個完整的、按時間順序排列的美國證券交易委員會（SEC）申報文件列表，不包括我們在其他地方提供的所有權申報。
| December 26, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response 14.5 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2) Rexahn Pharmaceuticals, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 761640 10 1 (CUSIP Numb |
|
| November 29, 2007 |
OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response 14. |
|
| May 23, 2005 |
Exhibit 2 POWER OF ATTORNEY The undersigned, as a Section 13(d) reporting person of Rexahn Pharmaceuticals, Inc. |
|
| May 23, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Rexahn Pharmaceuticals, Inc. - - (Name of Issuer) Common Stock, par value $0.0001 per share - - (Title of Class of Securities) 761640 10 1 - - (CUSIP Number) Sung-Guan Choi KT&G Corporation 100 Pyoungchon-dong Daedeok-gu Taejon City, Korea 306-130 011-82-2-3404-4521 - - (N |
